1. The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation
    Kandi Xu et al, 2021, Frontiers in Oncology CrossRef
  2. Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer
    Huan Feng et al, 2020, Frontiers in Molecular Biosciences CrossRef
  3. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
    Federica Saponaro et al, 2020, Frontiers in Molecular Biosciences CrossRef
  4. 68Ga-cyc-DX600 PET/CT in ACE2-targeted tumor imaging
    Fangyuan Ren et al, 2023, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
  5. Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges
    Seyyed M. R. Kazemi-Bajestani et al, 2012, Cardiology Research and Practice CrossRef
  6. The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
    Juanjuan Xu et al, 2017, Frontiers in Physiology CrossRef
  7. New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis
    Anderson J. Ferreira et al, 2012, International Journal of Hypertension CrossRef
  8. The Surging Mechanistic Role of Angiotensin Converting Enzyme 2 in Human Pathologies: A Potential Approach for Herbal Therapeutics
    Priyadarshini Gupta et al, 2023, Current Drug Targets CrossRef
  9. Is RAS the Link Between COVID-19 and Increased Stress in Head and Neck Cancer Patients?
    Anem Iftikhar et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  10. Risk of lung cancer and renin–angiotensin blockade: a concise review
    Tobias Rachow et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
  11. COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response
    Serhiy Souchelnytskyi et al, 2021, Scientific Reports CrossRef
  12. Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours
    Jan Meiners et al, 2021, Biomedicines CrossRef
  13. Evaluation of 68Ga- and 177Lu-Labeled HZ20 Angiotensin-Converting Enzyme 2-Targeting Peptides for Tumor-Specific Imaging
    Qian Zhang et al, 2022, Molecular Pharmaceutics CrossRef
  14. 20(S)-Protopanaxadiol Inhibits Angiotensin II-Induced Epithelial- Mesenchymal Transition by Downregulating SIRT1
    Yuchen Wang et al, 2019, Frontiers in Pharmacology CrossRef